Idiotype Manipulation for Autoimmune Diseases: Where Are We Going?

References

• Williams W. M., Isenberg D. A. Idiotypes and autologous antiidiotypes in human autoimmune disease — some practical and theoretical observations. Autoimmunity 1994; 17: 343–352
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y., Isenberg D. A. The Mosaic of Autoimmunity. Elsevier, Amsterdam 1989
   Google Scholar
• Coutinho A. The network theory: 21 years later. Scand. J. Immunol. 1995; 42: 3–8
   Google Scholar
• Horsfall A., Isenberg D. A. Idiotypes and autoimmunity. A review of their role in human disease. Autoimmunity 1988; 1: 429–468
   Google Scholar
• Zouali M., Stollar B. D., Schwartz R. D. Origin and diversification of anti-DNA antibodies. Immunol. Rev. 1988; 105: 137–159
   PubMed Web of Science ®Google Scholar
• Isenberg D. A., Williams W. M., Axford J., Bakimer R., Bell D., Casaseca-Grayson T., et al. Comparison of DNA antibody idiotypes in human sera: An international collaborative study of 19 idiotypes from 11 different laboratories. J. Autoimmunity 1990; 3: 393–414
   PubMed Web of Science ®Google Scholar
• Kalunian K. C., Panosian-Sahakian N., Ebling F. M., Cohen A. H., Louie J. S., Kaine J., Hahn B. H. Idiotypic characteristics of immunoglobulins associated with systemic lupus erythematosus. Studies of antibodies deposited in glomeruli of humans. Arthritis Rheum. 1989; 32: 513–522
   PubMedGoogle Scholar
• Tsao B. P., Ebling F. M., Roman C., Panosian-Sahakian N., Calame K., Hahn B. H. Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. J. Clin. Invest. 1990; 85: 530–540
   PubMedGoogle Scholar
• Morgan A., Isenberg D. A., Naparstek Y., et al. Shared idiotypes are expressed on mouse and human anti-DNA autoantibodies. Immunology 1985; 56: 394–400
   Google Scholar
• Staines N. A., Word F. J., Denbury A. R., Mitchiner J., Hartley O., Eilat D., Isenberg D. A., Bansal S. Primary sequence and location of the idiotypes of V-88, a DNA binding monoclonal antibody, determined by idiotype scanning with synthetic peptides on pins. Immunology 1993; 78: 371–378
   Google Scholar
• Zouali M., Migliorini P., Mackworth-Young C., Stollar B. D. Nucleic acid-binding specificity and idiotypic expression of canine anti-DNA antibodies. Eur. J. Immunol. 1988; 18: 923–927
   Google Scholar
• Zouali M., Diamond B. Idiotype-mediated intervention in systemic lupus erythematosus. J. Autoimmunity 1990; 3: 381–388
   Google Scholar
• Grayzel A., Solomon A., Cranow C., Diamond B. Antibodies elicited by pneumococcal antigens bear an anti-DNA associated idiotype. J. Clin. Invest. 1991; 87: 842–846
   PubMed Web of Science ®Google Scholar
• El Roiey A., Sela O., Isenberg D. A., Feldman R., Colaco B. C., Kennedy R. C., Shoenfeld Y. The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) and anti-polynucleotide activity. Clin. Exp. Immunol. 1987; 67: 507–715
   Google Scholar
• Lundkvist I., Coutinho A., Varela F., Holmberg D. Evidence for a functional idiotypic network among natural antibodies in normal mice. Proc. Natl. Acad. Sci., USA. 1989; 86: 5074–5078
   PubMed Web of Science ®Google Scholar
• Muriyoi T., Sasaki T., Hatakeyama A., Shibata S., Susuki M., Seino J., Yoshinaga K. Clonotypes of anti-DNA antibodies expressing specific idiotypes in immune complexes of patients with active lupus nephritis. J. Immunol. 1990; 144: 3856–3861
   Google Scholar
• Weisbart R. H., Noritake D. T., Wong A. L., Chan G., Kacena A., Colburn K. K. A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus. J. Immunol. 1990; 144: 2653–2658
   PubMed Web of Science ®Google Scholar
• Watts R., Ravirajan C. T., Wilkinson L. S., Williams W. M., Griffiths M., Butcher D., Horsfall A., Staines N. A., Isenberg D. A. Detection of human and murine common idiotypes of DNA antibodies in tissues and sera of patients with autoimmune diseases. Clin. Exp. Immunol. 1991; 87: 267–2673
   Google Scholar
• Isenberg D. A., Spellerberg M., Williams W., Griffiths M., Stevenson F. Identification of a role for the 9G4 idiotope in systemic lupus erythematosus. Brit. J. Rheumatol. 1993; 32: 876–882
   PubMedGoogle Scholar
• Potter K. N., Li Y., Pascual V., et al. Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH, 4.21 gene segment. J. Exp. Med. 1993; 178: 1419–1428
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y., Mozes E. Pathogenic idiotypes of autoantibodies in autoimmunity: Lessons from new experimental models of SLE. FASEB J. 1990; 9: 2646–2651
   Google Scholar
• Isenberg D. A., Katz D., Le Page S., Knight B., Tucker L., Maddison P., Hutchings P., Watts R., Andre-Schwartz I., Schwartz R. S., Cooke A. Independent analysis of the 16/6 idiotype lupus model. A role for an environmental factor. J. Immunology 1991; 147: 4172–4177
   PubMed Web of Science ®Google Scholar
• Puccetti A., Koizumi T., Migliorini P., Andre-Schwartz J., Barret K. J., Schwartz R. S. An immunoglobulin light chain from a lupus-prone mouse induces autoantibodies in normal mice. J. Exp. Med. 1990; 171: 1919
   PubMed Web of Science ®Google Scholar
• Stocks M. R., Williams D. C., Maini R. N. Differential induction of lupus associated antinuclear antibodies in MRL mice by monoclonal anti-Sm antibodies. Clin. Exp. Immunol. 1987; 67: 492–499
   PubMed Web of Science ®Google Scholar
• Dang H., Ogawa N., Takei M., Lazaridis K., Talal N. Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a cross reactive idiotype 4B4. J. Immunology 1993; 151: 7260–7267
   Google Scholar
• Zhou S. R., Whitaker J. N. Use of complementary peptides and their antibodies in T-cell-mediated autoimmune disease: experiments with myelin basic protein. Immunomethods 1994; 5: 136–147
   Google Scholar
• Gram Y. M., De Baets M. H. Molecular and structural characterization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis. Adv. Neuroimmunol. 1994; 4: 457–474
   Google Scholar
• Krolick K. A., Zoda T. E., Thompson P. A. Examination of characteristics that may distinguish diseasecausing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis. Adv. Neurolmmunol. 1994; 4: 475–493
   Google Scholar
• Thompson P. A., Edlund S. A., Krolick K. A. Identification of an idiotype associated with antibodies responsible for neuromuscular dysfunction in rats with experimental autoimmune myasthenia gravis. Clin. Immunol. Immunopathol. 1995; 75: 57–67
   Google Scholar
• Ruf J., Ferrand M., Durand-Gorde J. M., Carayon P. Autoantibodies and monoclonal antibodies directed to an immunodominant antigenic region of thyroglobulin interact with thyroperioxidase though an interspecies idiotype. Autoimmunity 1994; 19: 55–62
   PubMed Web of Science ®Google Scholar
• McCormack J. M., Crossley C. A., Ayoub E. M., Harley J. B., Cunningham M. W. Poststreptococcal anti-myosin antibody idiotype assoicated with systemic lupus erythematosus and Sjogren's syndrome. J. Infect. Dis. 1993; 168: 915–921
   Web of Science ®Google Scholar
• Jacob L., Tron F. Induction of anti-DNA autoantiidiotypic antibodies in NZB × NZW F1 mice: possible role for specific immunosuppression. Clin. Exp. Immunol. 1984; 58: 293–299
   Google Scholar
• Hahn B. N., Ebling F. Suppression of murine lupus nephritis by administration of an antiidiotypic antibody to anti-DNA. J. Immunol. 1984; 132: 187–190
   PubMed Web of Science ®Google Scholar
• Teitelbaum D., Rauch J., Stollar B. D., Schwartz R. D. In vivo effects of antibodies against a high frequency idiotype of anti-DNA antibodies in MRL mice. J. Immunol. 1984; 132: 1282–1285
   PubMed Web of Science ®Google Scholar
• Hahn B. N., Ebling F. Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies. J. Clin. Invest. 1983; 71: 728–1736
   Google Scholar
• Zouali M., Jolivet M., LeClerc C., Ravisse P., Audibert F., Eyquem A., Chedid L. Suppression of murine lupus autoantibodies to DNA by administration of muramyl dipeptide and syngeneic anti-DNA IgG. J. Immunol. 1985; 135: 181–186
   Google Scholar
• Brennan F. M., Williams D. G., Boville D., Stocks M. R., Maini R. N. Administration of monoclonal anti-Sm antibody prolongs the survival and renal function of MRL- lpr/lpr mice. Clin. Exp. Immunol. 1986; 65: 42–50
   Google Scholar
• Uner A. H., Knupp C. J., Tatum A. H., Gavalchin J. Treatment with antibody reactive with the nephritogenic anti-idiotype IdLNF, suppresses its production and leads to prolonged survival of (NZB × SWR) F1 mice. J. Autoimmunity 1994; 7: 27–34
   PubMed Web of Science ®Google Scholar
• Mamula M. J., Fatenejad S., Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 1994; 152: 1453–1461
   PubMed Web of Science ®Google Scholar
• Weiss S., Bogen B. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. 1989; 86: 282–286
   PubMed Web of Science ®Google Scholar
• King C. A., Wills M. R., Hemblin T. J., Stevenson F. K. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells. Cell Immunol. 1993; 147: 411–424
   PubMed Web of Science ®Google Scholar
• Ebling F. M., Tsao B. P., Singh R. R., Sercarz E., Hahn B. H. A peptide derived from an autoantibody can stimulate T cells in the (NZB × NZW) F1 mouse model of systemic lupus erythematosus. Arthritis Rheum. 1993; 36: 355–364
   Google Scholar
• Pascual V., Cha S., Gershwin M. E., Capra J. D., Leung P. S. Nucleotide sequence anallysis of natural and combinatorial anti-PDC-E2 antibodies in patients with primary biliary cirrhosis. Recapitulating immune selection with molecular biology. J. Immmunol. 1994; 152: 2577
   Web of Science ®Google Scholar
• Ikematsu H., Ichiyoshi Y., Schettino E. W., Nakamura M., Casali P. VH and V kappa segment structure of anti-insulin IgG autoantibodies in patients with insulin-dependent diabetes mellitus. Evidence for somatic selection. J. Immunol. 1994; 152: 1430–1441
   PubMed Web of Science ®Google Scholar
• Randen I., Potter K. N., Li Y., Thompson K. M., Pascual V., Forre O., Natvig J. B., Capra J. D. Complementarity-determining region 2 is implicated in the binding of staphylococcal protein A to human immunoglobulin VH111 variable regions. Eur. J. Immunol. 1993; 23: 2682–2686
   PubMedGoogle Scholar
• Demaison C., Chastagner P., Theze J., Zouali M. Somatic diversification in the heavy chain variable region genes expressed by human autoantibodies bearing a lupus-associated nephritogenic anti-DNA idiotype. Proc. Natl. Acad. Sci. USA. 1994; 91: 514–518
   PubMed Web of Science ®Google Scholar
• Noonan D. J., Kofler R., Singer P. A., Cardenas G., Dixon F. J., Theofilopoulos A. N. Delineation of a defect in T cell receptor beta genes of NZW mice predisposed to autoimmunity. J. Exp. Med. 1986; 163: 644–653
   PubMed Web of Science ®Google Scholar
• Kotzin B. L., Barr V. L., Palmer E. A large deletion within the T-cell receptor beta-chain gene complex in New Zealand white mice. Science 1985; 229: 167–171
   PubMed Web of Science ®Google Scholar
• Ghatak S., Sainis K., Owen F. L., Datta S. K. T-cell-receptor beta- and I-A beta-chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB × SWR crosses. Proc. Natl. Acad. Sci., USA. 1984; 84: 6850–6853
   Google Scholar
• Yanagi Y., Hirose S., Nagasawa R., Shirai T., Malk T. W., Tada T. Does the deletion with T cell receptor beta-chain gene of NZW mice contribute to autoimmunity in (NZB × NZW) F-1 mice. Eur. J. Immunol. 1986; 16: 1179–1182
   PubMed Web of Science ®Google Scholar
• Mountz J. D., Smith T. M., Toth K. S. Altered expression of self-reactive T cell receptor V beta regions in autoimmune mice. J. Immunol. 1990; 144: 2159–2166
   PubMed Web of Science ®Google Scholar
• Acha-Orbea H., Mitchell D., Timmermann L., Wraith D. C., Tausch G. S., Waldor M. K., Zamvil S. S., McDevitt H. O., Steinman L. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 1988; 54: 263–273
   PubMed Web of Science ®Google Scholar
• Banerjee S., Haqqi T. M., Luthra H. S., Stuart J. M., David C. S. Possible role of V (beta) T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J. Exp. Med. 1988; 167: 832–839
   PubMed Web of Science ®Google Scholar
• Heber-Katz E., Acha-Orbea H. The V-region disease hypothesis: Evidence from autoimmune encephalomyelitis. Immunol. Today 1989; 10: 164–169
   PubMedGoogle Scholar
• Frank M. B., McArthur R., Harley J. B., Fujisaku A. Anti-Ro(SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients. J. Clin. Invest. 1990; 85: 33–39
   PubMed Web of Science ®Google Scholar
• Seboun E., Robinson M. A., Doolittle T. H., Ciulla T. A., Kindt T. J., Hauser S. L. A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell 1990; 57: 1095–1100
   Google Scholar
• Oksenberg J. R., Stuart S., Begovich A. B., Bell R. B., Erlich H. A., Steinman L., Bernard C. C.A. Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brain of multiple sclerosis patients. Nature 1990; 345: 344–346
   PubMed Web of Science ®Google Scholar
• Wilson K. B., Quayle A. J., Suleyman S., Kjeldsen-Kragh J., Forre O., Natvig J. B., Capra J. D. Heterogeneity of the TcR repertoire in synovial fluid T lymphocytes responding to BCG in a patient with early rheumatoid arthritis. Scand. J. Immunol. 1993; 38: 102–112
   PubMed Web of Science ®Google Scholar
• Mantegazza R., Andreetta F., Bernasconi P., et al. Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. J. Clin. Invest. 1993; 91: 2880–2886
   PubMed Web of Science ®Google Scholar
• Sumida T., Yonaha F., Maeda T, et al. T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. J. Clin. Invest. 1992; 89: 681–685
   PubMed Web of Science ®Google Scholar
• Ben-Nun A., Liblau R. S., Cohen L., Lehmann D., Tournier-Lasserve E., Rosenzweig A., Jingwu Z., Raus J. C. M., Bach M A. Restricted T-cell receptor V (beta) gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: Predominant genes vary in individuals. Proc. Natl. Acad. Sci. USA. 1991; 88: 2466–2470
   PubMed Web of Science ®Google Scholar
• Oksenberg J. R., Panzara M. A., Begovich A. B., et al. Selection for T cell receptor VP-DP-JP gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993; 362: 68–70
   PubMed Web of Science ®Google Scholar
• Burns F. R., Li X., Shen N., Offner H., Chou Y. K., Vandenbark A. A., Heber-Katz E. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 1989; 169: 27–39
   PubMed Web of Science ®Google Scholar
• Sun D., Qin Y., Chiuba J., Eppien J. T., Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 1988; 332: 843–845
   PubMed Web of Science ®Google Scholar
• Lohse A. W., Mor F., Karin N., Cohen I. R. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 1989; 244: 820–822
   PubMed Web of Science ®Google Scholar
• Howell M. D., Winters S. T., Olee T., Powell H. C., Carlo D. J., Brostoff S. W. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989; 246: 668–670
   PubMed Web of Science ®Google Scholar
• Vandenbark A. A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989; 341: 541–544
   PubMed Web of Science ®Google Scholar
• Offner H., Hashim G. A., Vandenbark A. A. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 1991; 251: 430–432
   PubMed Web of Science ®Google Scholar
• James J. A., Gross T., Scofield R., Harley J. B. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J. Exp. Med. 1995; 181: 453–461
   PubMedGoogle Scholar
• Hafler D. A., Cohen I., Benjamin D. S., Weiner H. L. T cell vaccination in multiple sclerosis: a preliminary report. Clin. Immunol. Immunopathol. 1993; 62: 307–313
   Google Scholar
• Chou Y. K., Morrison W. J., Weinberg A. D., Dedrick R., Whitham R., Bourdette D. N., Hashim G., Offner H., Vandenbark A. A. Immunity to TcR peptides in multiple sclerosis: II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides. J. Immunol. 1994; 152: 2520–2529
   PubMed Web of Science ®Google Scholar
• Bourdette D. N., Whitham R. H., Chou Y. K., Morrison W. J., Atherton J., Kenny C., Liefeld D., Hashim G. A., Offner H., Vandenbark A. A. Immunity to TcR peptides in multiple sclerosis: I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides. J. Immunol. 1994; 152: 2510–2519
   Google Scholar